2d
Investor's Business Daily on MSNViking Therapeutics Skids Despite 'Rapid' Enrollment In Obesity Pill StudyViking Therapeutics stock skidded Wednesday despite the "encouraging" speed with which the company enrolled patients in an obesity study.
Goldman Sachs analyst Ben Andrews initiated coverage with a Buy rating on Viking Holdings Ltd (VIK – Research Report) today and set a price ...
LOS ANGELES--(BUSINESS WIRE)--Viking® (www.viking.com) (NYSE: VIK) today announced it has taken delivery of the Viking Nerthus, the company’s newest Viking Longship®. The delivery took place ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results